1.
Malik YS
et.al. Emerging novel coronavirus
(2019-nCoV)—current scenario, evolutionary perspective based on genome analysis
and recent developments. Veterinary Quarterly. 40; 2020: 68-76.
2.
Shivom, Goswami S,
Pal N, Singh RP, Singh A, Kumudhavalli MV. A Meticulous Interpretation on a
Sanguinary Disease COVID-19. Res. J. Pharma. Dosage Forms and Tech. 12;
2020:231-233.
3.
Mankar SD, Jadhav
RS, Gaikwad K. Corona Viruses - Current Knowledge - A Review. Research J.
Science and Tech. 12; 2020: 163-166.
4.
Rajashree GD,
Abhijit NS, Sahil SB. Novel Corona Virus: One Biological Disaster of 2020.
Research J. Science and Tech. 12; 2020: 147-156.
5.
Wang, Y., Wang,
Y., Chen, Y., and Qin, Q. Unique epidemiological and clinical features of the
emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control
measures. Journal of medical virology. 92; 2020: 568-576.
6.
Rodríguez-Morales,
AJ, MacGregor K, Kanagarajah S, and Patel D. Going global–Travel and the 2019
novel coronavirus. Travel medicine and
infectious disease. 33; 2020:101578.
7.
Akshay R. Yadav,
Shrinivas K. Mohite. A Novel Approach for Treatment of COVID-19 with
Convalescent Plasma. Res. J. Pharma. Dosage Forms and Tech. 12; 2020:227-230.
8.
Dipak Nalawade, R.
K. Godge, S. D. Magar. Analytical Method Development and Validation of
Ritonavir: A Review. Research J. Science and Tech. 12; 2020: 157-162.
9.
Lu, H. Drug
treatment options for the 2019-new coronavirus (2019-nCoV). Bioscience trends. 14; 2020: 69-71.
10. Pandey P, Jitendra Subhash Rane, Aroni Chatterjee,
Abhijeet Kumar, Rajni Khan, Amresh Prakash and Shashikant Ray Targeting
SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals:
an in-silico study for drug development. Journal of Biomolecular Structure and
Dynamics. 2020:
DOI:10.1080/07391102.2020.1796811
11. Hong EH, Song JH, Kim SR, Cho J, Jeong B, Yang H, and
Chang SY. Morin Hydrate Inhibits Influenza Virus entry into Host Cells and Has
Anti-inflammatory Effect in Influenza-infected Mice. Immune Network. 20; 2020:
12. Turshudzhyan, A. Anticoagulation Options for
Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy. Cureus 12; 2020: 5.
13. Nam GS, Lee, KS, and Nam KS. Morin hydrate inhibits
platelet activation and clot retraction by regulating integrin αIIbβ3, TXA2,
and cAMP levels. European Journal of Pharmacology. 865; 2019: 172734.
14. Berman H, Henrick K, Nakamura H, and Markley JL. The
worldwide Protein Data Bank (wwwPDB): ensuring a single, uniform archive of PDB
data. Nucleic acids research, 35; 2007: D301-D303
15. Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li
X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K, Li F,
Jiang R, Yang X, You T, Liu X, and Yang
H. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature.
582; 2020: 7811.
16. Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu,
G., Gindulyte, A., ... and Wang, J. PubChem substance and compound databases.
Nucleic acids research, 44; 2016 :1213
17. Elmezayen, A. D., Al-Obaidi, A., Şahin, A. T.,
andYelekçi, K. Drug repurposing for coronavirus (COVID-19): in silico screening
of known drugs against coronavirus 3CL hydrolase and protease enzymes. Journal
of Biomolecular Structure and Dynamics. 2020:
1-13
18. Anand K, Palm GJ, Mesters JR, Siddell SG, Ziebuhr J,
and Hilgenfeld R. Structure of coronavirus main proteinase reveals combination
of a chymotrypsin fold with an extra α-helical domain. EMBO J. 21; 2002:
3213–3224
19. DeLano WL. Pymol: An open-source molecular graphics
tool. CCP4. Newsletter on protein crystallography, 40; 2002: 82-92.
20. Chagas CM, Moss S, and Alisaraie L. Drug metabolites
and their effects on the development of adverse reactions: Revisiting
Lipinski’s Rule of Five. International journal of pharmaceutics, 549;
2018:133-149
21. Yang H, Sun L, Li W, Liu G, and Tang Y. In Silico
Prediction of Chemical Toxicity for Drug Design Using Machine Learning Methods
and Structural Alerts. Front Chem. 2018; 6: 129.
22. Jo S, Kim S, Shin DH, and Kim MS. Inhibition of
SARS-CoV 3CL protease by flavonoids. Journal of enzyme inhibition and medicinal
chemistry, 35; 2020: 145-151
23. Hsia CW, Wu MP, Velusamy M, Hsia CH, Chou DS, Tsai CL,
and Sheu JR. (2018). Novel therapeutic agent against platelet activation in
vitro and arterial thrombosis in vivo by morin hydrate. International Journal
of Molecular Sciences, 19; 2018: 2386.
24. Kulkarni, AD, and Belgamwar VS. Influence of novel
carrier Soluplus® on aqueous stability, oral bioavailability, and anticancer
activity of Morin hydrate. Drying Technology. 37; 2019: 1143-1161
25. Forli S, Huey R, Pique ME, Sanner, MF, Goodsell DS, and
Olson AJ. Computational protein–ligand docking and virtual drug screening with
the AutoDock suite. Nature protocol.11;2016: 905-919
26. Sasikumar R, Govindasamy M, Chen S, Liu YC, Ranganathan
P, Rwei S. Electrochemical determination of morin in Kiwi and Strawberry fruit
samples using vanadium pentoxide nano-flakes. Journal of Colloid and Interface
Science. 504; 2017: 626-632